Synthetic lethality: a step forward for personalized medicine in cancer
Author:
Funder
NCI
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference163 articles.
1. The origin of variations in sexual and sex-limited characters;Bridges;Am. Nat.,1922
2. Genetics of natural populations. XIII. Recombination and variability in populations of Drosophila pseudoobscura;Dobzhansky;Genetics,1946
3. Combination therapy in combating cancer;Mokhtari;Oncotarget,2017
4. A meta-analysis of combination therapy versus single-agent therapy in anthracycline-and taxane-pretreated metastatic breast cancer: results from nine randomized Phase III trials;Xu;Onco Targets Ther.,2016
5. Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review;Fogel;Contemp. Clin. Trials Commun.,2018
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Aqueous Extracts of Ocimum gratissimum Sensitize Hepatocellular Carcinoma Cells to Cisplatin through BRCA1 Inhibition;International Journal of Molecular Sciences;2024-08-01
2. New Horizons of Synthetic Lethality in Cancer: Current Development and Future Perspectives;Journal of Medicinal Chemistry;2024-07-02
3. CSSLdb: Discovery of cancer-specific synthetic lethal interactions based on machine learning and statistic inference;Computers in Biology and Medicine;2024-03
4. A systematic analysis of the landscape of synthetic lethality-driven precision oncology;Med;2024-01
5. Cell context-specific Synthetic lethality Prediction and Mechanism Analysis;2023-09-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3